Stock Watch Lists

Stock Hotlist: Strong Conviction Buys

July 2, 2023

Picking the wrong stocks can decimate your portfolio. The wrong stocks will eat away at your long-term profits. They’re pure portfolio poison. But the right stocks can make you rich.

With over 4000 stocks to choose from, the task of selecting the right stocks can prove to be nearly impossible unless you’re spending hours each day combing the markets. That’s why we’ve done it for you. We sort through thousands of stock ideas and narrow them down to a few that seem primed for solid price action in the near future.

We strongly believe that these three tickers are poised to move in the coming days and weeks. To learn more about these stocks and what makes them stand out among the rest, continue to the full article.

ON Semiconductor Corp (ON)

Semiconductor giant Onsemi is firing on all cylinders with a large market footprint in exciting growth sectors like automotive computing. ON share price is up nearly 300% in the three years since the summer of 2020, and revenue has grown 28.3% over the past twelve months. The US-based chipmaker has solidified its reputation as a top player among its auto/industrial peers. However, several factors support the case that plenty of runway is left for this bet on an electric future.

Following ON’s stellar performance of the past few years, the stock still looks undervalued at just 15.8x earnings and 19.3x 12-months forward earnings. In fact, it’s currently one of the cheapest tech names in the S&P 500.

Onsemi recently initiated a $3 billion share repurchase plan at its final 2022 financial update. The new shareholder return policy is good through 2025. Management targets about 50% of free cash flow to be returned to stockholders each year. If the company uses up all $3 billion in authorized buybacks through 2025, that would equate to nearly 10% of the current market cap or roughly 3% a year in cash returns to shareholders over the next three-year stretch. Not too shabby.

Bank of America sees ON as a top-3 global/top US vendor of smart power and sensing chips for EVs, and they’re alone. Onsemi holds a highly attractive 1.37 (overweight) rating from the Wall Street pros who cover it.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ON” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Nike Inc (NKE)

There are compelling reasons to invest in one of the most well-known sports apparel brands ever put on the market; the company I’m talking about is Nike Inc. With solid demand on its side, NKE’s direct, wholesale, and digital sales have all grown over the years. NKE also has control over its inventory levels, which increased in line with the company’s sales. Also, a benefit for NKE is its market share expansion and its dominance over its competitors. Adidas and UnderArmour, NKE’s two biggest challengers, have faced difficulties, only solidifying NKE’s market position.

NKE’s stock is down year-to-date by 4.50%, it shows TTM revenue of $50.68 billion at $3.57 per share, and it made a same-period net income of $5.5 billion via its 10.82% profit margin. NKE has a PEG ratio of 1.88x, an ROE of 37.34%, and year-over-year revenue growth+13.97%). For the most recent quarter, NKE reported an EPS of $0.79 per share vs. the $0.55 projected by analysts (a 44.57% surprise), and it reported $12.39 billion in sales vs. the $11.48 expected (a 7.92% beat). NKE has an annual dividend yield of 1.21% and a quarterly payout of 34 cents ($1.36/year) per share. With fra ee cash flow of $2.87 billion and a 10-day average volume of 9.91 million shares, NKE has a median price target of $138, with a high of $160 and a low of $95, allowing the potential for a 43% price increase. NKE has 22 buy ratings and ten hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”NKE” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

PayPal Holdings Inc. (PYPL)

Unlike many fintech companies, digital payment giant Paypal is incredibly profitable. Yet its stock is down more than 80% from its July 2021 ATH a, and it trades at a reasonable 29 times price to earnings, well below its historical average P/E of 50.

With e-commerce activity on the decline since the thick of the pandemic, PayPal is seeing slower growth. Unrelenting high levels of inflation have put a dent in discretionary spending, which has hurt PayPal, but thanks to its firm financial footing, the company has plenty of room to handle a possible prolonged economic downturn. Despite estimates calling for roughly 20% earnings growth this year, PayPal stock trades below 16 times free cash flow and about 14 times operating cash flow, indicating that investors may be underestimating its recovery potential. Among 48 polled analysts, 33 say to Buy PYPL, and 15 call it a Hold. There are no Sell ratings for the stock. A median 12-month price target of $89.50 represents a 35% increase from today’s price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”PYPL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Dump These Stocks Now

Editorial Staff

July 1, 2023

The right stocks can make you rich and change your life.

The wrong stocks, though… They can do a whole lot more than just “underperform.” If only! They can eviscerate your wealth, bleeding out your hard-won profits.

They’re pure portfolio poison.

Surprisingly, not many investors want to talk about this. You certainly don’t hear about the danger in the mainstream media – until it’s too late.

That’s not to suggest they’re obscure companies – some of the “toxic stocks” I’m going to name for you are in fact regularly in the headlines for other reasons, often in glowing terms.

I’m going to run down the list and give you the chance to learn the names of three companies I think everyone should own instead.

But first, if you own any or all of these “toxic stocks,” sell them today

Affirm Holdings Inc (AFRM)

Our first stock to avoid is Affirm Holdings, a fintech firm specializing in “buy now, pay later” services, and it faces significant hurdles. Despite an initial surge in growth facilitated by AFRM’s partnership with Peloton (PTON), there has been a struggle to sustain momentum. AFRM’s most recent quarter saw results that confirmed its lack of profitability. Also, being a consumer credit business, AFRM will likely experience mounting challenges amid a dim economic outlook.

AFRM’s stock is up year-to-date by 93.74%; you’ll notice a trend where, after seeing a YTD gain, you’ll see negative numbers from there on. For instance, AFRM has an ROE (return on equity) of -37.97% and a 3.65 beta, which indicates how prone the stock is to volatility. AFRM has a TTM revenue of $1.51 billion, yet it lost $965 million thanks to its -64.12% profit margin. AFRM shows negative year-over-year growth in net income (-276.21%), EPS (-263.16%), and net profit margin (-250.36%). With a 10-day average volume of roughly 24 million shares, AFRM has a median price target of $16, with a high of $20 and a low of $6; this suggests a potential -68% drop from its current price. AFRM has 10 hold ratings and 3 sell ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AFRM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Walgreens Boots Alliance Inc (WBA)

Wallgreens this week cut its fiscal fourth-quarter earnings guidance and reported a weaker-than-expected fiscal third-quarter profit. Guidance for the company’s burgeoning Health segment which was expected to flip to profitability in the third quarter was slashed.

Walgreens now expects fiscal 2023 adjusted EBITDA between losses of $380 million and $340 million. The company’s previous guidance called for a profit at the top end of the range. Management also lowered preliminary 2024 guidance amid lingering “operational challenges.” The current consensus among 19 polled analysts is to Hold WBA stock.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”WBA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Abrdn Income Credit Strategies Fund (ACP)

Closed-end fund, Abrdn Income Credit Strategies Fund offers a high forward dividend yield of 14.35%. However, Over the past year, ACP shares have fallen by more than 20%. Further declines may be ahead for two reasons.

First, higher interest rates have had an inverse effect on the value of ACP’s portfolio of low-rated debt securities. Second, the current economic downturn could increase the default risk of ACP’s holdings. This may also result in another dividend cut, like the one 16.7% cut implemented in 2020.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ACP” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

The A.I. Advantage: Three Stocks in Position to Benefit Greatly

Editorial Staff

June 30, 2023

Today, top analysts are not just looking at AI stocks alone—some of which have skyrocketed; a perfect example is Nvidia (NVDA), which is up year-to-date by 178.07%—but also at information technology (IT) stocks that are set up to benefit from the technology.

Many companies directly involved in AI may have risen too high and too quickly, making them risky buys at this point. The stocks I’ll be focusing on today each have the following:

– The ability to utilize and invest in AI quickly

– Digital and cloud computing offerings

– A history of adjustability during market turbulence

– Past, current, and future profitability

Additionally, these three stocks have some of the lowest debt-to-equity ratios I’ve ever seen…

Globant SA (GLOB)

One stock that stands out as a top choice is Globant SA (GLOB), due to its position as a prominent player in digital transformation (DX) and its strong partnerships with established blue-chip clients. GLOB‘s success in the global DX market can be attributed to expanding its services into new industries and benefiting from clients’ increased IT outsourcing. These factors contribute to GLOB‘s growing market share and make it an appealing stock to consider while it flies slightly under the radar.

GLOB, slightly up year-to-date by 3.89%, is trading near the bottom of its range, leaving plenty of room. GLOB has a TTM revenue of $1.85 billion at $3.34 per share, from which it has profited $149 million on the back of its 8.03% net margin. GLOB has an ROE (return on equity) of 10.03%, a PEG ratio of 1.58x, revenue growth of +17.7% year-over-year, and a great D/E (debt to equity) measure of 8.31%. GLOB recently beat analysts’ projections on both EPS and revenue. With a 10-day average volume of roughly 410 thousand shares, GLOB has a median price target of $205, with a high of $240 and a low of $180, representing the potential for a 37.5% jump from its current price. GLOB has a consensus Strong Buy rating.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GLOB” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Accenture PLC (ACN)

Accenture plc (ACN) presents a compelling investment opportunity due to its robust data and AI practices, boasting a workforce of roughly 40,000 experts across 50 delivery centers. With plans to expand to over 80,000 delivery professionals, ACN is clearly committed to growth. ACN‘s strategic partnerships with hyper-scalers and emphasis on AI acquisitions position it as a prominent AI beneficiary. Along with a juicy dividend, ACN is an attractive stock to keep a close eye on.

ACN’s stock is currently up by 11.47% YTD and is trading around the middle of its existing 52-week range. From $63.5 billion in TTM revenue at $11.22 per share, ACN has made a net income of $7.16 billion via its 11.27% profit margin and has an ROE of 30.02%. At its latest earnings call, ACN reported $3.15 per share

vs. $3.00 per share expected to beat analysts’ EPS projections by 5.08%, and it shows year-over-year growth in revenue (+2.51%) and net income (+12.54%), with a stunningly low 0.21% debt-to-equity figure. ACN has a 1.51% annual dividend yield and a quarterly payout of $1.12 ($4.48/year) per share. With a 10-day average volume of 3.5 million shares, ACN’s median price target is $340, with a high of $377 and a low of $290; this represents an almost 27% price upside. ACN has 17 buy ratings and 10 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ACN” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Epam Systems Inc (EPAM)

EPAM Systems Inc. (EPAM) emerges as an excellent stock choice due to its distinct focus on high-end engineering. By diligently constructing and maintaining the essential infrastructure to facilitate widespread AI implementation across enterprises, EPAM leverages its exceptional talent pool with a digitally focused approach. This positions EPAM as a prime contender to capitalize on the growing demand for AI solutions.

EPAM’s stock is down year-to-date by 32.78% and is at the bottom of its 52-week range, despite having a positive SMA (simple moving average). EPAM has a TTM revenue of $4.86 billion at $7.23 per share, from which it has profited a net income of $432 million through its margin of 8.88%. With a PEG ratio of 1.81x, EPAM has a 30.67% ROE with a D/E (debt to equity) measure of 0.90%. At its last earnings report, EPAM’s EPS was $2.47 vs. the $2.34 expected by analysts (a 5.36% surprise), and it shows YOY growth in revenue (+3.36%) and net income (+14.01%). With a 10-day average volume of almost 900 thousand shares, EPAM has a median price target of $240, with a high of $300 and a low of $215, representing a potential price jump of more than 36% from where it currently sits. EPAM has 8 buy ratings and 8 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”EPAM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Dividend Excellence: What Makes These High Yielders So Great?

Editorial Staff

June 30, 2023

The Federal Reserve—the nation’s central bank in charge of monetary policies—began raising the federal funds rate (to combat inflation) from 0.75% to 1% in May 2022, which was already a concern…

That same rate is now up to 5.15% as of June 15th, 2023.

The era of low interest rates is coming to an end. Inflation is surging. Investors are seeking higher returns from the stocks in their portfolios. The smart move is to turn to reliable income stocks, and it’s important to hold positions in dividend stocks that compete well with the rest of the marketplace.

Why? Capital gains and price appreciation. And these are among the very best…

OneMain Holdings Inc (OMF)

Right off the bat, an unconventional opportunity among the bunch is OneMain Holdings (OMF). As a mid-cap financial firm valued at over $5 billion, OMF offers a unique proposition. Specializing in personal loans and insurance, particularly auto loans, credit cards, and life insurance, OMF benefits from the upward trend in interest rates. This favorable market condition allows OMF to enjoy increased profit margins. Notably, OMF is attractively priced, and investors are rewarded with a very nice dividend.

OMF has been doing well, currently up by 28.82%, with a positive SMA (simple moving average) and a solid ROE (return on equity) of 24.41%. OMF has a TTM revenue of $2.65 billion at $6.19 per share, and it profited $754 million via its 29.45% net margin in the same period. With a PEG (price/earnings/growth) ratio of 0.27x and a forward P/E (price to earnings) ratio of 6.3x, OMF is forecasted to report $1 billion in sales at $1.31 per share for the current fiscal quarter. OMF has an annual dividend yield of 9.32%, a quarterly payout of $1.00 ($4.00/year) per share, and a 60.91% payout ratio. As assigned by analysts, OMF has a median price target of $50, with a high of $62 and a low of $41, representing the potential for a 44.5% price jump from where it currently sits. OMF has 11 buy ratings and 3 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”OMF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Ambev SA (ABEV)

Regarding high dividends, the reliability and stability of the underlying business are crucial. ABEV acts as an excellent example in this case. Shareholders of ABEV can find reassurance in the enduring demand for alcohol, making it an attractive investment option. A subsidiary of Anheuser-Busch, ABEV boasts a remarkable portfolio of renowned brands, including Budweiser, Stella Artois, and Corona. Analysts anticipate 12.5% earnings growth for ABEV in 2023.

ABEV is currently up year-to-date by 16.91% and has a beta score of 0.65, deeming it safe from market volatility. ABEV has a TTM revenue of $81.8 billion at $0.20 per share and has made a profit of $14.75 billion through its 18.02% net margin. With a 0.99x PEG ratio, ABEV most recently beat analysts’ EPS and revenue forecasts by 20.57% and 2.07%, respectively, also showing year-over-year growth in revenue (+11.35%), net income (+8.40%), and EPS (+4.55%). ABEV has an annual dividend yield of 3.83%, a quarterly payout of 12 cents ($0.48/year) per share, and a 67.21% payout ratio. With a 10-day average volume of 15.39 million shares, ABEV has an average price target of $3.50, with a high of $5 and a low of $2.70; this represents the potential for a more than 57% price jump. ABEV has 11 buy ratings and 5 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ABEV” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Chevron Corp (CVX)

Amidst the cyclical nature of the energy industry, Chevron (CVX) shines as a dependable dividend stock. While the industry experiences fluctuations, CVX‘s production of oil and natural gas remains in consistent demand, even amidst the rise of renewable power. Notably, CVX boasts an exceptionally strong balance sheet, and during periods of market weakness, it strategically takes on debt to sustain its operations and dividend payments. CVX‘s ability to navigate this intricate market landscape while consistently rewarding investors with a strong dividend payment is a testament to its proficiency.

CVX is in a great “buy the dip” position, as it’s currently down year-to-date by 14.47%. With TTM revenue of $234 billion at $18.53 per share, CVX’s same-period profit has been $35.78 billion on the back of its 15.28% net margin. CVX has a 13.42% ROE, a PEG ratio of 1.8x, and a remarkably low 4.46% D/E (debt to equity) measure. Reporting $3.55 per share vs. $3.39 as expected by analysts, CVX beat them out by 4.71% and also beat revenue projections by a 2.64% margin. CVX has a 3.87% annual dividend yield, with a quarterly payout of $1.51 ($6.04/year) per share. With a 10-day average volume of roughly 10 million shares, CVX has a median price target of $188, with a high of $212 and a low of $167, suggesting the potential for a price upside of more than 35%. CVX has 14 buy ratings and 12 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CVX” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Exclusive Content: Blue-Chip Dividend Stocks Trading Drastically Below Fair Value

Editorial Staff

June 29, 2023

Within the realm of investment strategies and emerging market trends, blue-chip dividend stocks stand out. These industry leaders boast stability, renowned brands, and generous dividends, making them a low-risk option when seeking profitability.

Opportunities await the astute investor, and I’ve found a few that meet the criteria I laid out above. These popular buy-rated stocks are undervalued, and each shows a promising price upside…

General Dynamics Corp (GD)

General Dynamics (GD) is a prominent defense contractor that has solidified its position within its industry. GD’s primary focus is the operation of its “Gulfstream” commercial jet program, which excels in manufacturing high-quality, long-range private jets. The luxury goods market has experienced a global upswing in recent years, propelling demand for GD’s planes. Additionally, the allure of private jets has grown further since the pandemic, with more affluent folks hopping on board.

GD’s numbers are substantial. Its stock is down year-to-date by 14.89%, is trading near the very bottom of its existing 52-week range, and has a safe 0.83 beta score. GD shows TTM revenue of $40 billion at $12.22 per share, from which it has profited $3.39 billion in net income via its 8.50% profit margin. GD has an ROE of 18.27%, a PEG ratio of 1.77x, a P/S (price to sales) ratio of 1.47x, and a D/E (debt to equity) of 63.38%. GD most recently bested analysts’ projections on EPS and revenue by 1.84% and 6.20%, respectively. GD has a 2.50% annual dividend yield and a quarterly payout of $1.32 ($5.28/year) per share. With roughly $2 billion in free cash flow, GD has a median price target of $252.50, with a high of $325 and a low of $218, suggesting a price leap of over 54% from where it is now. GD has 19 buy ratings and six hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Danaher Corp (DHR)

Another one to consider is Danaher Corp. (DHR), a top blue-chip stock focused on healthcare that was initially an industrial conglomerate but had since strategically navigated mergers and acquisitions, resulting in remarkable returns. As it concludes the spin-off of its water division, DHR will solely concentrate on healthcare, particularly in the growing bioprocessing market. While sales dipped after the pandemic, this presents an attractive entry point for investors to get a piece of DHR.

Down by 11.57% year-to-date, DHR is at the bottom of its 52-week range with a beta score of 0.80. DHR shows a TTM revenue of $30.95 billion at $9.29 per share, and it has made a net income of $6.85 billion on the back of its 22.40% profit margin. DHR has a PEG ratio of 2.17x, an ROE of 14.17%, and a D/E (debt to equity) of 40.66%. At its last earnings call, DHR reported EPS of $2.36 per share vs. $2.26 as predicted by analysts, beating their forecasts by 4.36%; it also beat revenue by a 1.59% margin. DHR has an annual dividend yield of 0.46% and a quarterly payout of 27 cents ($1.08/year) per share. With a 10-day average volume of 3.35 million shares, DHR has a median price target of $273, with a high of $328 and a low of $220, representing a potential price jump of nearly 40%. DHR has 21 buy ratings and seven hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”DHR” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Goldman Sachs Group Inc (GS)

I don’t shy away from reality in the markets. This year, Goldman Sachs (GS) has faced some challenges. The banking industry crisis and concerns over GS’s performance have contributed to slower operations, particularly affected by sluggish capital market conditions in 2022. However, there are reasons to remain optimistic about GS. Market conditions are rebounding, and the resurgence of high-profile IPOs, like Cava (CAVA), is expected to revive demand for GS’s services. Furthermore, Goldman is positioned for significant growth in its consumer business. GS’s dividend certainly sticks out:

GS’s stock is currently down by 8.60% and is near the bottom of its range. From $44.67 billion in TTM revenue at $28.08 per share, GS has profited $1.97 billion via a 22.63% net margin. With a PEG ratio of 0.7x, GS most recently reported EPS at $8.79 per share vs. $8.06 per share, as projected by analysts, beating their forecasts by a 9.08% margin. GS has an annual dividend yield of 3.19% and a quarterly payout of $2.50 ($10.00/year) per share. With $37 billion in operating free cash flow and a 10-day average volume of 2.65 million shares, GS has a median price target of $385, with a high of $470 and a low of $305; this indicates the potential for a nearly 50% price upside. GS has 17 buy ratings and nine hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GS” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

These Three Cheap Energy Earners Offer Incredible Returns

Editorial Staff

June 26, 2023

We’ve been talking about stocks lately that are obviously important in the world of marketplace happenings and trends, with AI being a prime example. The market moves fast, and while others have profited, some of us feel like we can’t find our way in. That’s okay! There are always other options.

Not all of us chase the “next big thing,” but instead try to invest safely, find a comfort zone, and take only calculated risks. Energy is an excellent space for this.

Today, I’m looking at three energy stocks that are down year-to-date, and the below-fair-value pricing leaves plenty of room for price appreciation. These are each in an ideal position to turn a profit.

I’ll now dive into these three energy stocks to expose their profitability. So, let’s check it out:

Vertex Energy Inc (VTNR)

A forward-thinking refining company, Vertex Energy (VTNR) specializes in the production and distribution of a diverse range of fuels, exploring both traditional and alternative sources. VTNR recently wrapped up its ambitious renewable diesel (RD) conversion project, marking a significant milestone for the business.

As a result, revenue soared, showcasing remarkable growth in VTNR’s products and refined treasures during Q1 2023. By embracing sustainable practices, VTNR may be at the forefront of the transition.

VTNR is down slightly year-to-date by 0.48%, has a 1.05 beta score, and shows 187.32% in TTM (trailing twelve-month) asset growth. VTNR’s TTM revenue is $3.4 billion, more than six times higher than its market cap of $517 million. With a PEG (price/earnings/growth) ratio of 0.44x, VTNR, during its last earnings call, reported EPS of $0.68 per share vs. the $0.15 expected, beating analysts’ forecasts by a whopping 341.6%. VTNR shows year-over-year growth in critical areas like revenue (+827.25%), net income (+1,284%), EPS (+950%), and net profit margin (+227.75%). With an operating free cash flow of $105 million and a 10-day average volume of 2.11 million shares, VTNR has a median price target of $11.50, with a high of $15 and a low of $8; this represents the potential for a more than 143% price increase from VTNR’s current position.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”VTNR” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Sunrun Inc (RUN)

Sunrun Inc. (RUN) is a top energy stock with a compelling valuation and, from what I can see, a lot of growth potential. RUN leads the untapped U.S. residential solar energy market, boasting a projected 15.3% annual growth rate until 2030. There have been concerns regarding short-term profitability, but longer-term forecasts are very bright for RUN. This is a great example of one of those “calculated risks” I mentioned in my introduction; don’t forget that there’s a lot of potential here.

RUN’s stock is currently down by 20.02% year-to-date, and there’s an argument to be made for it being undervalued—especially given the forecasts. RUN has TTM asset growth of 14.33% and TTM revenue of $2.42 billion at $0.10 per share. RUN has a P/S (price to sales) ratio of 1.76x and a P/B (price to book) ratio of 0.64x. Although missing on EPS, RUN reported $589.85 million in revenue vs. the $517.78 million projected by Wall Street analysts, surprising by a 13.92% margin and showing revenue growth (year-over-year) of 18.87%. For the current fiscal quarter, RUN is projected to report $621.6 million in sales with quarterly EPS growth of 78.58%. With a 10-day average trading volume of 7.92 million shares, RUN has a median price target of $33.53, with a high of $66 and a low of $25, suggesting a price increase of anywhere from 61% to 212%. Take a look at how RUN’s dip is rising back up.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”RUN” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Plug Power Inc (PLUG)

With its unique expertise in hydrogen fuel cells, which generate power from hydrogen and oxygen while emitting only water vapor, Plug Power Inc. (PLUG) utilizes them to surpass the reliance on lithium batteries in electric vehicles. For PLUG, supplying EV manufacturers is a little easier, given that there are costly regulations on lithium and its use. Despite any drawbacks, it is considered a leader in the space, and right now, PLUG shows the most potential out of all of its clean energy counterparts for long-term price appreciation… and it’s a substantial difference.

PLUG is down by 23.04% year-to-date and sits near the bottom of its existing 52-week range, showing that it might just be due for a comeback. With a TTM revenue of $770 million, PLUG’s current-quarter revenue is expected to come in at $251.9 million. Until reporting again on August 10th, PLUG could have

done a lot worse with its last earnings call, when it reported revenue of $210.29 million vs. the $207.76 million expected, beating analysts’ forecasts by 1.21%; it also shows year-over-year revenue growth of 49.35%, in addition to net profit margin growth of 11.62%. PLUG has a P/B (price to book) ratio of 1.57x and a refreshing D/E (debt to equity) measure of 15.15%. Showing forward 1-year EPS growth of 48.1% and a 10-day average volume of 26.91 million shares, PLUG has a median price target of $18.54, with a high of $78 and a low of $7.50. This represents a price upside of anywhere from 57% to 719% (as in seven hundred and nineteen) from its current position. Analysts are mostly bullish on PLUG; I can see why.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”PLUG” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Tech Titans: Three Must-Have A.I. Stocks for Your Portfolio

Editorial Staff

June 26, 2023

AI has already been with us for many years; we use it daily, yada yada… you know, I know, we all know. Nobody other than the insiders, though, could’ve predicted that in the first half of 2023, chatbot technology would suddenly send the stock market into a hysterical tech rally…

And, well, here we are. A lot of investors are leaning into it. But should we?

Many say yes, but the question is: to what degree? Should we be purely bullish and allocate our tech funds to one name? Not necessarily. ChatGPT is certainly a game-changer in many ways, but the stock exchange game hasn’t changed… not yet. Following trends, consider this a great list of options.

You likely know these names, but there’s a great reason you do: These are damn good ones…

Alphabet Inc (GOOGL)

Alphabet Inc. (GOOGL), the parent company of Google, recently introduced Bard, its own AI chatbot similar to ChatGPT. Bard leverages online information to provide quick and concise answers by accessing, compiling, and summarizing data. Rather than receiving a list of web pages from a search engine, users get a single, comprehensive solution. Although Bard encountered a misstep during its test launch, GOOGL has other AI offerings. GOOGL provides business AI tools and infrastructure through its Google Cloud Computing division. Considering GOOGL’s dedication to AI innovation, including the introduction of Bard and its existing AI solutions, it positions itself as a compelling AI stock investment opportunity.

GOOGL stock is currently up year-to-date by 37.67%, has a positive Simple Moving Average, and a 1.09 beta. GOOGL has TTM revenue of $58.59 billion at $4.45 per share, profiting more than $58 billion through its 20.58% net margin, and has an ROE (return on equity) of 22.76%. At its last earnings report, GOOGL reported EPS of $1.17 per share vs. $1.07 per share as predicted by analysts (a 20.58% surprise), and it has a free cash flow of almost $56 billion. GOOGL is forecasted to report $72.7 billion in sales at $1.33 per share for the current quarter. With a 10-day average volume of 32.4 million shares, GOOGL has a median price target of $130, with a high of $190.32 and a low of $100, representing a potential price upside of almost 57%. GOOGL has 48 buy ratings and five hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GOOGL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

NVIDIA Corp (NVDA)

The A100 chip by Nvidia Corp. (NVDA) provides the necessary computational power for chatbots like ChatGPT. However, NVDA is expanding its offerings beyond the A100 chip with DGX supercomputers, considered the ultimate hardware for machine learning. DGX supercomputers are actively deployed by NVDA worldwide, running continuously to refine data and process new forms of AI. NVDA CEO Jensen Huang refers to them as “modern AI factories.” Customers in various countries, including Japan, Ecuador, and Sweden, use NVDA’s DGX H100 supercomputer systems as intelligence manufacturing centers. These robust systems that NVDA is utilizing have already found applications in diverse fields such as legal research, healthcare, digital advertising, and higher education.

Recently hitting a market cap of $1 trillion, NVDA’s stock is up year-to-date by a resounding 193.18%. NVDA’s TTM revenue is $25.88 billion at $4.49 per share, and it made a net profit of $4.79 billion using its 18.52% net margin, and it has an ROE of 18.85%. NVDA has a PEG ratio of 2.45x and a D/E (debt to equity)

measure of 44.67%. NVDA has a modest dividend yield of 0.04% and a quarterly payout of 4 cents ($0.16/year) per share. NVDA, with a 10-day moving average of 53,23 million shares (people are catching on), NVDA has a median price target of $460, with a high of $600 and a low of $175, leaving room for more than 40% upside potential. NVDA has 47 buy ratings and seven hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”NVDA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

International Business Machines Corp (IBM)

International Business Machines (IBM) is a strong AI stock due to its Watson products offering AI and ML (machine learning) services. IBM’s solutions assist customers in enhancing decision-making and increasing profitability. With a portfolio of AI applications, IBM’s Watson enables improved customer service, cost reduction, outcome prediction, and workflow automation. Additionally, enterprise customers can utilize IBM’s Watson Studio to develop and expand their own AI applications. IBM’s strategic acquisitions, such as Turbonomic, Instana, and Databand.ai, further bolster its AI capabilities.

IBM is down year-to-date by 6.90% and has a 0.85 beta score. With $60.59 billion at $2.24 per share in TTM revenue, it made a net income of $2.05 billion via its 3.03% profit margin. IBM most recently beat analysts’ EPS forecasts by 9.73%, and it reports year-over-year revenue growth (+0.39%), net income (+26.47%), EPS (+24.69%), net profit margin (+25.97%), and operating income (+46.26%). IBM has an annual dividend yield of 5.06%, with a whopping quarterly payout of $1.66 ($6.64/year) per share through its generous 294.64% payout ratio. With a 10-day average volume of 4.79 million shares, IBM has a median price target of $140, with a high of $162 and a low of $110, suggesting a potential price jump of 23.5% from where it currently sits. IBM has five buy ratings and 11 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”IBM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Weekly Radar: Our Top Stock Picks for This Week

Editorial Staff

June 25, 2023

The major indices each declined more than 1% last week, putting an end to the impressive streak of eight consecutive weekly gains for the NASDAQ, five for the S&P 500, and three for the Dow. Concerns about further interest-rate hikes and a decelerating global economy weighed heavily on stocks.

Unfortunately, no crystal ball can tell us which stocks will present significant price action in the coming days. With over 4,000 publicly traded companies available in The U.S., staying ahead of potential moves can prove to be a challenging task that requires hours each day devoted to market research.

To provide our readers with a competitive edge, we sort through thousands of stock ideas each week and narrow them down to three that may be primed for big price jumps in the near future.

So what are the best tickers to have on your radar now? Get the inside scoop on the top stocks to watch this week here.

PayPal Holdings Inc. (PYPL)

Unlike many fintech companies, digital payment giant Paypal is incredibly profitable. Yet its stock is down more than 80% from its July 2021 ATH, and it trades at a reasonable 29 times price to earnings, well below its historical average P/E of 50.

Despite estimates calling for roughly 20% earnings growth this year, PayPal stock trades below 16 times free cash flow and about 14 times operating cash flow, indicating that investors may be underestimating its recovery potential. Among 48 polled analysts, 33 say to Buy PYPL, and 15 call it a Hold. There are no Sell ratings for the stock. A median 12-month price target of $89.50 represents a 35% increase from the current price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”PYPL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Nike Inc (NKE)

There are compelling reasons to invest in one of the most well-known sports apparel brands ever put on the market; the company I’m talking about is Nike Inc. (NKE). With solid demand on its side, NKE’s direct, wholesale, and digital sales have all grown over the years. NKE also has control over its inventory levels, which increased in line with the company’s sales. Also, a benefit for NKE is its market share expansion and its dominance over its competitors. Adidas and UnderArmour, its two biggest challengers, have faced difficulties, only solidifying Nike’s market position.

NKE’s stock is down year-to-date by 4.50%, it shows TTM revenue of $50.68 billion at $3.57 per share, and it made a same-period net income of $5.5 billion via its 10.82% profit margin. NKE has a PEG ratio of 1.88x, an ROE of 37.34%, and year-over-year revenue growth (+13.97%). For the most recent quarter, The company reported an EPS of $0.79 per share vs. the $0.55 projected by analysts (a 44.57% surprise), and it reported $12.39 billion in sales vs. the $11.48 expected (a 7.92% beat). The stock sports an annual dividend yield of 1.21% and a quarterly payout of 34 cents ($1.36/year) per share. With a free cash flow of $2.87 billion and a 10-day average volume of 9.91 million shares, NKE has a median price target of $138, with a high of $160 and a low of $95, allowing the potential for a 43% price increase.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”NKE” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

TEVA Pharmaceutical Industries LTD (TEVA)

The global leader in generic drugs, Teva Pharmaceutical, is currently trading at an undeniably low 3x forward price-to-earnings multiple. The stock is so cheaply priced right now because of its high debt load of $20.7 billion as of the end of March. But that’s down from $21.2 billion as of the end of last year. And with the company projecting up to $2.1 billion in free cash flow for 2023, it could have room to pay down more debt this year.

Teva recently announced an agreement with Johnson & Johnson that will allow it to launch its Stelara biosimilar, AVT04, in the U.S. market by Feb. 21, 2025—generating just under $10 billion in revenue for the healthcare giant last year. Stelara is a massive moneymaker for J&J and will provide consumers with a lower-priced alternative that could help accelerate Teva’s growth.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TEVA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Dump These Stocks Now

Editorial Staff

June 23, 2023

The right stocks can make you rich and change your life.

The wrong stocks, though… They can do a whole lot more than just “underperform.” If only! They can eviscerate your wealth, bleeding out your hard-won profits.

They’re pure portfolio poison.

Surprisingly, not many investors want to talk about this. You certainly don’t hear about the danger in the mainstream media – until it’s too late.

That’s not to suggest they’re obscure companies – some of the “toxic stocks” I’m going to name for you are in fact regularly in the headlines for other reasons, often in glowing terms.

I’m going to run down the list and give you the chance to learn the names of three companies I think everyone should own instead.

But first, if you own any or all of these “toxic stocks,” sell them today…

C3.ai Inc (AI)

C3.ai (AI) may have a catchy ticker symbol that aligns with the market’s enthusiasm for artificial intelligence. Still, there really isn’t much else to say about AI when it comes to considering it for our portfolios. AI is slow-moving, unprofitable, and lacks the potential to benefit from the current excitement surrounding consumer-facing AI. It isn’t certain that C3.ai will capitalize on the opportunity, making it a stock to avoid; it is largely inflated at this point, and, unfortunately, many of us were late to the rally.

AI’s stock is up year-to-date by an insane 285.52%, and the case for it being overvalued is an easy one to make when looking at the negative numbers. AI has a 2.61 beta and an ROE of -28.02% and shows $266 million in TTM revenue, from which it lost $268 million thanks to its crazy -100.77% profit margin. AI shows negative year-over-year growth in net income (-11.19%), net profit margin (-11.05%), and operating income (-29.65%). With a 10-day average trading volume of roughly 52 million shares, AI has a median price target of $23.50, with a high of $50 and a low of $14, suggesting the potential for a price decrease anywhere from -45% to -67%. AI has 6 buy ratings and 4 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AI” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Meta Materials (MMAT)

Semiconductor company Meta Materials develops and produces functional materials and nanocomposites, particularly in lithium battery materials. The micro-cap company is losing far more money than it’s bringing in. In the fourth quarter MMAT reported revenues of $1.4 million and operating expenses of $24.8 million. The company posted a net earnings loss of $79.1 million for the entire year.

Not to mention, the company is embroiled in litigation on accusations of involvement in “spoofing, naked short selling, market manipulation, and fraud.” Meta Materials share price is down 81% this year, falling to less than 25 cents per share.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”MMAT” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Mondelez International Inc. (MDLZ)

Recession fears and concerns around the financial sector have investors seeking refuge in consumer staples stocks to shore up their portfolios. However, based on technical analysis some of these traditionally defensive tickers now seem overbought. Case in point – Mondelez.

A stock is considered overbought if its 14-day RSI goes above 70, and is typically seen as an indicator to consider cutting back on exposure. By this measure, with an RSI of 89.2 MDLZ tops the list as one of the most overbought names from the S&P 500.Wall Street sees little-to-no upside potential for the stock over the next twelve months. According to FactSet, the average analyst price target for Mondelez implies an upside of just 3%.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”MDLZ” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Three MORE Dividend Discounts For Summer Peace of Mind

Editorial Staff

June 23, 2023

Given that it’s summertime, many of us like to take a break from the everyday hustle… However, what if I told you that there are plenty of stocks out there that can offer the following?

– A reliable, stable income stream

– Act as a buffer, safeguarding portfolios from declines

– Long-term wealth accumulation

– Resilience during market uncertainty

– Even more wealth accumulation through reinvestment plans

– Can be bought and held with confidence by long-term income investors

Of course, it’s all about picking the right dividend stocks, and that’s what I strive to do. Earlier this week I wrote about three undervalued dividend payers with low beta scores. If you missed that list you can find it here. With many so many attractive options available, the task of whittling my choices down to just three stocks proved to be more of a challenge than I could bare. Therefore, here are three MORE undeniably low-priced stocks that can increase your returns while you relax this summer…

Comcast Corp (CMCSA)

Comcast Corp. (CMCSA) is an attractive dividend stock to consider purchasing for several reasons: It’s stock is considered undervalued— and that pricing power helps it maintain stability in the broadband market. CMCSA has increased its dividend by around 17% annually since 2008, and it boasts a solid balance sheet. This makes CMCSA a compelling and reliable choice among its dividend-paying peers.

CMCSA is currently up year-to-date by 16.36%, and it has TTM revenue of $120 billion at $1.34 per share, from which it made a net income of $5.66 billion via its 4.71% net margin. CMCSA has a PEG (price/earnings/growth) ratio of 0.82x, a P/S (price to sales) ratio of 1.47x, a P/B (price to book) ratio of 2.06x, and a free cash flow of $10.37 billion. For its last earnings call, it reported EPS of $0.92 vs. the $0.83 expected by analysts (a 10.92% surprise), and CMCSA beat revenue projections by 1.28%. CMCSA has an annual dividend yield of 2.86%, a quarterly payout of 29 cents ($1.16/year) per share, and an 82.09% payout ratio. With a 10-day average volume of 16.6 million shares, CMCSA has a median price target of $46, with a high of $55 and a low of $36, representing a potential price jump of over 35% from its current position. CMCSA has 21 buy ratings and 11 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CMCSA” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Blackstone Inc (BX)

As one of the top undervalued stocks for Q2 2023, Blackstone (BX) presents an opportunity for investors with its price trading below its intrinsic, or true, value. With extensive expertise in alternative asset management, BX excels in revitalization through strategies like cost-cutting and acquisitions. BX‘s focus on dividend payouts aligns with the interests of income investors, and despite recent redemption requests for real estate income, the overall expectation is that it will maintain stability and generate consistent dividend payments. For these reasons, BX stands out as an attractive option.

Although BX stock is up year-to-date by 19.23%, it is stll trading near the bottom of its existing 52-week range. BX shows $4.26 billion in TTM revenue at $0.81 per share, and its same-period net income is $616.5 million through its profit margin of 14.46%. BX has a forward P/E (price to earnings) ratio of 18x, a PEG ratio of 0.53x, and estimated 3-5 year EPS growth of +26.1%. For its most recent earnings report, BX beat analysts on EPS, reporting $0.97 vs. the $0.95 predicted. BX has an annual dividend yield of 4.38%, with a

quarterly payout of 98 cents ($3.92/year) per share, and a staggering 543.21% payout ratio. With 3.12 million shares representing its 10-day average trading volume, BX has a median price target of $101.50, with a high of $115 and a low of $85; this suggest a more than 30% increase from where its price is currently positioned. BX has 15 buy ratings and 5 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”BX” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Abbvie Inc (ABBV)

Despite facing competition and a potential revenue decease due to its blockbuster immunology medicine, Humira, AbbVie Inc. (ABBV) remains an excellent dividend stock with attractive prospects. While ABBV‘s lineup of medicines, including Qulipta and its Botox franchise, will help offset Humira’s sales decline, other medications are expected to surpass peak annual sales in the next couple years and secure its momentum. As a “Dividend King” with 51 consecutive years of dividend increases, ABBV has raised its payouts by an impressive 270% since it split from Abbott Laboratories in 2013. ABBV‘s long-term business outlook remains strong, supporting sustained dividend growth for years to come.

ABBV is near the bottom of its existing 52-week range and is down year-to-date by 15.10%; despite this, it has a safe beta score of 0.55. ABBV shows TTM revenue of $56.75 billion at $4.24 per share, from which it made a profit of $7.5 billion in net income via its 13.37% margin, and it has a lucrative ROE (return on equity) of 51.28%. ABBV recently met analysts’ EPS forecasts, and shows projected 3-5 year EPS growth of 13.2% annually. ABBV has a 4.33% annual dividend yield, a quarterly payout of $1.48 ($5.92/year) per share, and a generous 134.35% payout ratio. With $21.6 billion in free cash flow and a 10-day average volume of 6.09 million shares, ABBV has a median price target of $163, with a high of $201 and a low of $135; this represents a potential 47% price upside. ABBV has 14 buy ratings and 13 hold ratings.

ON Semiconductor Corp (ON)

Nike Inc (NKE)

PayPal Holdings Inc. (PYPL)

Affirm Holdings Inc (AFRM)

Walgreens Boots Alliance Inc (WBA)

Abrdn Income Credit Strategies Fund (ACP)

Globant SA (GLOB)

Accenture PLC (ACN)

Epam Systems Inc (EPAM)

OneMain Holdings Inc (OMF)

Ambev SA (ABEV)

Chevron Corp (CVX)

General Dynamics Corp (GD)

Danaher Corp (DHR)

Goldman Sachs Group Inc (GS)

Vertex Energy Inc (VTNR)

Sunrun Inc (RUN)

Plug Power Inc (PLUG)

Alphabet Inc (GOOGL)

NVIDIA Corp (NVDA)

International Business Machines Corp (IBM)

PayPal Holdings Inc. (PYPL)

Nike Inc (NKE)

TEVA Pharmaceutical Industries LTD (TEVA)

C3.ai Inc (AI)

Meta Materials (MMAT)

Mondelez International Inc. (MDLZ)

Comcast Corp (CMCSA)

Blackstone Inc (BX)

Popular Posts

My Favorites